Global Asthma Drugs Market 2019 Industry Analysis, Share, Growth, Sales, Trends, Supply, Forecast 2025

Jun 7, 2019

WiseGuyReports.com adds “Global Asthma Drugs Market Insights, Forecast to 2025” reports to its database.

Pune, India - June 6, 2019 /MarketersMedia/ —

Asthma Drugs Market:

Executive Summary

Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors.
The American Academy of Allergy Asthma and Immunology classifies asthma under four categories: exercise-induced asthma, allergic asthma, occupational asthma, and childhood asthma. The Asthma and Allergy Foundation of America classifies asthma into two categories: allergic asthma and non-allergic asthma. It is an incurable disease but can be controlled with the help of diagnosis at the right time, followed by regular therapy.

The global Asthma Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Asthma Drugs market based on company, product type, end user and key regions.

Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/3342505-global-asthma-drugs-market-insights-forecast-to-2025

This report studies the global market size of Asthma Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Asthma Drugs in these regions.
This research report categorizes the global Asthma Drugs market by top players/brands, region, type and end user. This report also studies the global Asthma Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
GlaxoSmithKline
Novartis
Merck
Boehringer Ingelheim
AstraZeneca
Roche
Teva Pharmaceutical
Vectura Group

Market size by Product
Quick-relief Medications (Rescue Medications)
Medications for Allergy-induced Asthma
Market size by End User
Allergic Asthma
Non-Allergic Asthma

The study objectives of this report are:
To study and analyze the global Asthma Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Asthma Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Asthma Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Asthma Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Asthma Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Asthma Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

For further information on this report, visit – https://www.wiseguyreports.com/reports/3342505-global-asthma-drugs-market-insights-forecast-to-2025

Table of Contents

1 Report Overview

2 Global Growth Trends

3 Market Share by Key Players

4 Breakdown Data by Type and Application

5 United States

6 Europe

7 China

8 Japan

9 Southeast Asia

10 India

11 Central & South America

12 International Players Profiles

13 Market Forecast 2019-2025

14 Analyst’s Viewpoints/Conclusions

15 Appendix

Continuous…

Contact Info:
Name: Norah Trend
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Pune - 411028 Maharashtra, India
Phone: +1 (339) 368 6938 (US), +44 208 133 9349 (UK)
Website: https://www.wiseguyreports.com/reports/3342505-global-asthma-drugs-market-insights-forecast-to-2025

Source URL: https://marketersmedia.com/global-asthma-drugs-market-2019-industry-analysis-share-growth-sales-trends-supply-forecast-2025/521179

Source: MarketersMedia

Release ID: 521179

More News

What to consider if a company that made AI-related job cuts wants you back

Oct 30, 2026

What to consider if a company that made AI-related job cuts wants you back

NEW YORK — Companies around the world are increasingly citing artificial intelligence when slashing jobs, fueling anxiety that a lot more workers may lose their livelihoods to machines. Microsoft, Barclays Bank and supermarket chain Kroger are among the latest entries on a growing list of companies that have announced AI-related workforce reductions this year, including the elimination of jobs deemed redundant or shed to free up money for investing in the technology. But the job cuts of the AI era, which are affecting tens of thousands of people, occasionally have an epilogue. Some companies, after discovering that AI models, applications and agents don't perform as well as expected, end up rehiring laid-off workers to fill eliminated positions. It's unclear how common such reversals are, but they are happening often enough to acquire a nickname: the "AI boomerang." "Two years ago, we said, 'Would this happen?' and now we're saying, 'Yes, it is happening in real time,'" said Lucy Beaumont, a global senior vice president at SHL, a U.K.-based technology company that develops employment-related tests and tools. Hiring managers in fields including finance, marketing, law and health reported earlier this year that their companies had eliminated positions primarily because of AI or automation, only to hire again for the same or similar roles, according to recruitment and staffing firm Robert Half. The most frequently cited reasons for restoring dropped jobs included the technology needing more human oversight than anticipated and its inability to replicate institutional knowledge, the firm said. "When you need critical thinking, collaboration, creativity, institutional knowledge, those are things that AI just can't replicate," Bill Driscoll, a senior district president at Robert Half, said. "And I think that's where companies are starting to realize, 'Wow, we really do need people to do these jobs.'" Klarna, the Swedish provider of buy now, pay later services, began recruiting human customer service representatives again last year. CEO Sebastian Siemiatkowski acknowledged in an interview with Bloomberg News that the company's reliance on an AI chatbot to cut costs had gone too far. In June, Ford said it had hired or promoted 350 veteran engineers after AI tools the automaker deployed to do quality control work did not perform at the expected level. "AI utilization has been an important part of our quality gains and that — along with deep technical expertise of our teams — is a powerful combination," a Ford spokesperson told The Associated Press. However, companies don't always broadcast their U-turns on shifting resources or responsibilities from employees to AI systems, Beaumont said. "Maybe their shareholders love that they did this right-sizing motion... and then they have to turn around and quietly, with their tail between their legs, admit that they weren't ready for that or they shouldn't have done that," she said. Management experts offered employment advice for workers as companies make greater use of AI tools and consider — or reconsider — their staffing needs while assessing the technology's capabilities. Rehiring suggests the invisible work of humans is not easily replaced When companies use AI to perform tasks previously done by people, they often miss the invisible work employees do beyond their formal job descriptions, said Betsy Summers, a principal analyst on the Future of Work team at market research and advisory firm Forrester. That might include sensing emotions and moods, holding impromptu meetings and putting in extra effort when feeling inspired or otherwise motivated, Summers said. "We don't know all the work that's required to do things well within the organization," she said. "The citizenship behaviors of team cohesion and team building and making sure that you have trust within your team, none of that is accounted for. So when you rip out humans who are doing that work and then expect agents to be able to then deliver exactly what humans have delivered, they are frequently mistaken." Another factor that complicates assigning more work to AI-powered tools is that company procedures for tasks such as data processing and bookkeeping are not always well documented, experts said. "Organizations are not spending enough time doing the up-front work to really truly understand workflows and where humans add value in the process," said Brooks Holtom, a professor of management at Georgetown University's McDonough School of Business. In roles such as customer service, AI agents and chatbots frequently need to refer questions and complaints to a worker who can recognize emotions, assess the severity or complexity of a problem and respond creatively within established policies, Holtom said. "It's that combination of creativity but staying in the guardrail that's really hard for a machine to figure out," he said. Figure out what gives you a competitive edge as a human As companies redirect resources toward AI, current employees and those asked to come back might want to emphasize skills that complement the technology, such as emotional intelligence and sound judgment, Holtom said. "Really try to be able to articulate, what's your value proposition as a human?" Holtom said. "Don't be afraid to lean into the technology as well, and understand how to differentiate yourself from what machines do well. Embrace that, understand that, and you can become uniquely qualified to help with implementation." Empathy is a human quality that technology has not fully mastered, Beaumont said. "Think about an angry customer. They want to be listened to, they want to be heard, they really want a human on the other end of the line," Beaumont said. "Can an AI replace that right now in a way that feels meaningful to individuals? Perhaps not." Know your leverage and use caution if you're asked back Many people are understandably reluctant to return to a company that laid them off as part of a reorganization around artificial intelligence, according to Beaumont. "To come back to a business where you've been let go, replaced by AI, to be asked back to that business, your trust is gone, your psychological safety there, your relationship with the employer, and that's very, very difficult to build back," she said. Workers offered their old jobs back are asking for more money and to know how AI might impact future staffing, Beaumont said. Requesting additional training and a clear explanation of your opportunities for advancement could be part of the discussion, she said. Communicate ways you would contribute value as a returning employee, outlining a new job description "that leverages the technology but also your expertise," Holtom said. You could end up in a higher-ranking position that pays more than the one you left, he said. Before accepting an offer, seek a commitment such as a one-year renewable contract that includes a buyout clause if the job is terminated in less than a year, Holtom suggested. Don't discount the distinctly human values of motivation and curiosity, which make people efficient and effective, Summers said. "Within our societies, work serves a broader purpose than just creating value for shareholders or customers or constituents," she added. "Work serves a human purpose as well. It's the manifestation of our search for meaning and purpose. We want to contribute to our communities as human beings."

Butcher Boy earns Bib Gourmand distinction in 2027 Michelin Guide

Oct 30, 2026

Butcher Boy earns Bib Gourmand distinction in 2027 Michelin Guide

MANILA, Philippines — Butcher Boy has earned a Bib Gourmand distinction in the 2027 Michelin Guide Philippines, moving up from its Michelin-Selected status in the 2026 edition and joining a select group of restaurants recognized for serving quality food at accessible prices.  The recognition was announced during the official awarding ceremony at the Manila Marriott Hotel on Thursday, Oct. 29, attended by President Ferdinand Marcos Jr.  Butcher Boy was among only two restaurants promoted from the Michelin-Selected category to Bib Gourmand this year. The distinction recognizes establishments that offer good-quality food at reasonable prices.  Butcher Boy Philippines CEO Dino Chua received the award, marking another milestone for the restaurant, which has continued to establish its presence in the local dining scene.  The recognition follows the restaurant's opening of its new and expanded location at Alabang West Parade along Daang Hari Road in Muntinlupa City in 2026. Led by Chua, the move marked a new chapter for the brand, allowing it to reach more diners in southern Metro Manila while maintaining its signature contemporary Asian-fusion cuisine.  Originally founded by Michelin-starred chef Andrew Walsh of Singapore's acclaimed Cure, Butcher Boy built its following at its former Makati location before relocating to Alabang to accommodate a bigger dining space and connect with a wider community.  Its culinary approach combines Southeast Asian flavors with Western cooking techniques, offering dishes such as its signature chicken laksa dumplings, fried chicken bao, Asian tacos, pork adobo and a variety of steaks, alongside carefully crafted cocktails.  The chicken laksa dumplings were among the dishes highlighted by Michelin inspectors.  During the restaurant's grand opening, Marketing Head Aubrey S. Mojica described its concept as “where east meets west,” emphasizing that while the menu had been expanded, the restaurant remained committed to preserving the quality, atmosphere and dining experience that patrons had come to expect.  Mojica also underscored the importance of customer service, saying the restaurant's identity goes beyond its food to include the experience it provides to diners.  With its latest Michelin recognition, Butcher Boy strengthens its position in the Philippine dining scene, bringing its combination of Asian-fusion flavors, steaks and accessible dining to the Alabang community.  Butcher Boy is located at Alabang West Parade, Daang Hari Road, Muntinlupa City. For reservations, call 0939-868-0531.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.